Inactive Instrument

Optimer Pharmaceuticals, Inc. Stock

Equities

End-of-day quote Nasdaq Other stock markets
- ^USD	-

Optimer Pharmaceuticals, Inc. : Pre-Market Analysis: Inovio Pharmaceuticals Inc., Sequenom Inc., and Optimer Pharmaceuticals Inc.	13-10-04	PR
Optimer Pharmaceuticals, Inc. : Today's Research: Inovio Pharmaceuticals Inc., Onyx Pharmaceuticals Inc., Sequenom Inc. and Optimer Pharmaceuticals Inc.	13-08-29	PR
Optimer Pharmaceuticals, Inc. : Laboratory Permits, Pending FDA Approvals, Clinical Study Presentations, and Financial Results Release - Research Report on Illumina, Theravance, Acorda, Synta, and Optimer	13-08-12	PR
Optimer Pharmaceuticals, Inc. : Ryan & Maniskas, LLP Announces Investigation of Optimer Pharmaceuticals, Inc.	13-08-01	PR
Optimer Pharmaceuticals, Inc. : Optimer Reports Second Quarter 2013 Financial Results	13-08-01	PR

Sector

	1st Jan change	Capi.
CSL LIMITED	-5.32%	84.57B
SAMSUNG BIOLOGICS CO.,LTD.	+2.11%	39.93B
BIOGEN INC.	-25.81%	27.93B
UCB	+52.92%	24.21B
BIOMARIN PHARMACEUTICAL INC.	-6.16%	17.17B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-31.09%	13.93B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-6.58%	12.3B
INCYTE CORPORATION	-15.73%	11.84B
SWEDISH ORPHAN BIOVITRUM AB	-3.00%	7.91B